Humana INC Form 4 insider transactions

Paul John Smith, a Director of Humana Inc, received 544 shares of common stock on August 1, 2026.

Frederick John Crawford, a Director of Humana Inc, received 544 shares of common stock on August 1, 2026.

Humana Inc. director Kurt J. Hilzinger reported transactions involving restricted stock units, including deferrals and dividend reinvestments.

Humana Inc. Chief Financial Officer Celeste Mellet reported transactions involving company common stock and restricted stock units.

Humana Inc. Chief Information Officer Japan Mehta reported the acquisition of 9,448 shares of common stock on May 1, 2026.

David Dintenfass, President of Enterprise Growth at Humana Inc., reported transactions involving the acquisition of common stock and options.

Humana Inc. President & CEO James A. Rechtin reported transactions involving company stock, including acquisitions and holdings of options and restricted stock units.

Humana Inc. reports that Chief Human Resources Officer Michelle A. O'Hara acquired 10,485 shares of common stock on May 1, 2026.

Humana Inc. reports that Director Robert Stuart Field was granted 852 restricted stock units under the 2026 Stock Incentive Plan.

Humana Inc. Chief Legal Officer Joseph C. Ventura reported a significant acquisition of company stock on May 1, 2026, alongside details of his existing derivative holdings.

Sanjay K. Shetty, President of CenterWell at Humana Inc., reported transactions involving the acquisition of common stock and the exercise of stock options.

Humana Inc. reports a significant acquisition of company stock by President of Medicare Advantage, Aaron Martin.

Sanjay K. Shetty, President of CenterWell at Humana Inc., reported transactions involving the acquisition of common stock and stock options.

Humana Inc. President of Insurance George Renaudin II filed a Form 4 disclosing routine retirement plan transactions and phantom stock unit adjustments.

Director Kurt J. Hilzinger acquired 536 restricted stock units in Humana Inc. as part of a director fee conversion.

Humana's Chief Legal Officer, Joseph C. Ventura, reported the acquisition of 1,035 shares and the disposition of 478 shares for tax purposes following the vesting of performance stock units.

Humana's President of Insurance, George Renaudin II, reported the vesting of performance stock units and a subsequent tax-related share disposition.

Humana's SVP, Chief Accounting Officer & Controller, John-Paul W. Felter, reported recent acquisitions and a tax-related disposition of company common stock.

Sanjay K. Shetty, President of CenterWell at Humana Inc., acquired 810 shares of common stock in a pre-arranged open market transaction.

Humana's President of Enterprise Growth, David Dintenfass, reported the vesting of restricted stock units and related tax-driven share disposals.

Humana's President of Medicare Advantage, Aaron Martin, reported the acquisition of 17,031 restricted stock units.

Humana's President & CEO, James A. Rechtin, reported the vesting of restricted stock units and a subsequent sale of shares to cover tax liabilities.

Humana Director David T. Feinberg increased his beneficial ownership through the acquisition of restricted stock units and deferred stock unit conversions.

A Humana Inc. director acquired additional restricted stock units through annual fees and dividend reinvestment, deferring payout until resignation.

Humana Director John W. Garratt increased his beneficial ownership through the acquisition of common stock and restricted stock units, primarily from deferred director fees and dividend reinvestments.

Humana Director Marcy Klevorn increased her beneficial ownership of the company's stock units through annual fees and dividend reinvestment, deferring payout until her resignation.

Humana Director Frank A. D'Amelio reported the transfer of 20,634 common shares to a trust and the acquisition of 766 restricted stock units as part of his compensation.

Humana Inc. Director Jorge S. Mesquita acquired 766 restricted stock units, increasing his indirect beneficial ownership to 4,127 shares.

Humana Director Kurt J. Hilzinger acquired additional restricted stock units through annual fees, dividend reinvestment, and cash fee conversion, deferring payout until resignation.

Humana Director Karen Katz reported an increase in her beneficial ownership of Restricted Stock Units through annual fees and dividend reinvestments.